ClinicalTrials.Veeva

Menu

Effect of Dental Scaling on Helicobacter Pylori Eradication and Reinfection (Scaling and Hp)

G

Goztepe Training and Research Hospital

Status

Unknown

Conditions

Helicobacter Pylori Infection

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Patients who had received H.pylori eradication treatment will be categorised as eradication and reinfection status and whether dental scaling has any influence on these results.

Full description

Patients over 18 years with no comorbidities especially liver, cardiac and haemorrhagic diathesis and giving informed consent will be categorised according to their status of dental scaling, eradication and reinfection rates of h.pylori.

Statistical examination will include the multiple regression and Chi-Square.

The result will emphasize the influence of dental scaling on eradication (Presence of Hp cure 1-6 months after treatment) and reinfection ( reappearance of Hp 12 months later than the treatment).

Enrollment

300 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients over 18 with h.pylori positivity and received anti-Hp treatment giving informed consent to analyse of their data on this subject.

Exclusion criteria

  • Comorbidities with cardiac, liver and medical contraindication to perform dental scaling.

Trial design

300 participants in 2 patient groups

Patients with scaling and patients without scaling
Description:
No drug
Helicobacter eradicated or non-eradicated

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems